RAP 0.00% 20.5¢ resapp health limited

I think BL qualified that statement by adding in the next two...

  1. 6,746 Posts.
    lightbulb Created with Sketch. 857
    I think BL qualified that statement by adding in the next two years...meaning he expected dx to be slow of the mark but doing better than sleepcheck after a couple of years. So if Sleepcheck can get up around the $2 million in the next 12 to 18 months then possibly with dx chiming in the 2022 year should see expenses covered...stop the rot...on several levels.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.